We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.95%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.8B
AUM Growth
-$8.26B
(-8%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
21.55%
Holding
2,181
New
100
Increased
1,075
Reduced
690
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$671M |
| 2 |
Broadcom
AVGO
|
+$416M |
| 3 |
ServiceNow
NOW
|
+$264M |
| 4 |
Arista Networks
ANET
|
+$262M |
| 5 |
Autodesk
ADSK
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$284M |
| 2 |
Microsoft
MSFT
|
+$281M |
| 3 |
Micron Technology
MU
|
+$275M |
| 4 |
Teradyne
TER
|
+$274M |
| 5 |
KLA
KLAC
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.64% |
| 2 | Industrials | 14.32% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 7.97% |
| 5 | Utilities | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
ADMA Biologics
ADMA
$2.19B
| $370K | ﹤0.01% |
41,036
-120,798
| -75% | -$1.91M |
|
1627
HNI Corp
HNI
$3.55B
| $368K | ﹤0.01% |
11,036
+1,871
| +20% | +$82.9K |
|
1628
FMC
FMC
$1.28B
| $368K | ﹤0.01% |
21,366
+3,487
| +20% | +$52.1K |
|
1629
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $365K | ﹤0.01% |
2,854
-2,631
| -48% | -$328K |
|
|
BBT
1630
Beacon Financial Corp
BBT
$2.69B
| $363K | ﹤0.01% |
12,114
| – | – |
|
1631
First Bancorp
FBNC
$2.72B
| $363K | ﹤0.01% |
6,446
-95
| -1% | -$5.42K |
|
1632
OneSpaWorld
OSW
$2.7B
| $362K | ﹤0.01% |
15,777
| – | – |
|
|
CURB
1633
Curbline Properties
CURB
$3.46B
| $362K | ﹤0.01% |
14,033
+2,162
| +18% | +$55.4K |
|
1634
Intercorp Financial Services
IFS
$6.06B
| $361K | ﹤0.01% |
7,200
| – | – |
|
|
LTC
1635
LTC Properties
LTC
$2.09B
| $360K | ﹤0.01% |
9,696
+1,444
| +17% | +$54.3K |
|
1636
First Busey Corp
BUSE
$2.58B
| $359K | ﹤0.01% |
14,189
| – | – |
|
1637
PENN Entertainment
PENN
$2.57B
| $358K | ﹤0.01% |
23,829
+3,368
| +16% | +$46.8K |
|
|
STEL
1638
DELISTED
Stellar Bancorp
STEL
| $358K | ﹤0.01% |
9,778
| – | – |
|
1639
Celcuity
CELC
$4.49B
| $358K | ﹤0.01% |
+3,136
| New | +$342K |
|
1640
Vishay Intertechnology
VSH
$5.15B
| $357K | ﹤0.01% |
19,859
+3,271
| +20% | +$59.5K |
|
1641
Amneal Pharmaceuticals
AMRX
$6.15B
| $356K | ﹤0.01% |
28,657
| – | – |
|
1642
LeMaitre Vascular
LMAT
$1.88B
| $356K | ﹤0.01% |
3,259
+169
| +5% | +$16.1K |
|
1643
Huntsman Corp
HUN
$1.78B
| $356K | ﹤0.01% |
26,719
-5,013
| -16% | -$60.8K |
|
|
OS
1644
DELISTED
OneStream Inc
OS
| $354K | ﹤0.01% |
14,769
+1,485
| +11% | +$34.8K |
|
1645
Apple Hospitality REIT
APLE
$3.71B
| $351K | ﹤0.01% |
30,524
+4,146
| +16% | +$50.1K |
|
1646
Dyne Therapeutics
DYN
$4.89B
| $351K | ﹤0.01% |
19,372
+6,409
| +49% | +$111K |
|
1647
ePlus
PLUS
$2.32B
| $351K | ﹤0.01% |
4,659
| – | – |
|
1648
Capri Holdings
CPRI
$1.77B
| $350K | ﹤0.01% |
19,845
+2,051
| +12% | +$43.4K |
|
1649
Quaker Houghton
KWR
$2.91B
| $349K | ﹤0.01% |
2,806
+284
| +11% | +$42K |
|
1650
DNOW Inc
DNOW
$3.04B
| $347K | ﹤0.01% |
29,177
+3,685
| +14% | +$49.9K |
|
Similar funds
Pictet Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Pictet Asset Management held 2,181 positions worth $94.8B, down 8% from $103B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management's Q1 2026 filing shows 100 new, 1,075 increased, 690 reduced and 79 closed positions. Its largest new stake was AstraZeneca: 3,481,864 shares worth $675M. The largest sale was Lam Research, an estimated $284M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2026 buy was AstraZeneca: 3,481,864 shares worth $675M.
- Pictet Asset Management added most to Broadcom in Q1 2026, an estimated $416M increase.
- Pictet Asset Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
- Pictet Asset Management fully exited CyberArk in Q1 2026, selling an estimated $104M.
- Pictet Asset Management's ten largest holdings make up 22% of its $94.8B portfolio in Q1 2026.
- Pictet Asset Management opened 100 new positions and closed 79 in Q1 2026.
- Pictet Asset Management's portfolio value fell 8% quarter-over-quarter to $94.8B.
Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.